Israeli oncology therapeutics firm Alpha Tau Medical has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy).
Read more here.
Israeli oncology therapeutics firm Alpha Tau Medical has secured breakthrough device designation from the US Food and Drug Administration (FDA) for its Alpha DaRT (Diffusing Alpha-emitters Radiation Therapy).
Read more here.